CSL - Ebit

Aktienkurs
139.19
Täglich Wechseln
-1.04 -0.74%
Monatlich
-2.38%
Jährlich
-40.28%
Q2 Prognose
135.92




Ebit Veränderung Datum
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Arca Biopharma USD -34.43M 326K 2025-12
aTyr Pharma USD 24.47M 24.7M 2025-12
Bio Path USD -488K 4.07M 2025-09
Brainstorm Cell Therapeutics USD -2.05M 526K 2025-09
Cara Therapeutics USD -5.94M 3.55M 2025-09
CSL USD 2.64B 116M 2025-12
Curis USD -7.88M 4.31M 2025-12
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Immunic USD -22.81M 756K 2024-06
Infinity Pharmaceuticals USD -10.12M 1.39M 2023-06
Minerva Neurosciences USD -4.37M 1.71M 2024-09
TherapeuticsMD USD -1.77M 699K 2023-09